Hengyuan Li
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Oncology top 10%
- Rheumatology top 5%
- Surgery
- Topics
- Sarcoma Diagnosis and Treatment (17 papers)Bone Tumor Diagnosis and Treatments (12 papers)Fluorine in Organic Chemistry (9 papers)
In The Last Decade
Hengyuan Li
65 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 123
- Molecular Biology 342
- Pulmonary and Respiratory Medicine 341
- Oncology 272
- Rheumatology 272
- Surgery 180
Countries citing papers authored by Hengyuan Li
This map shows the geographic impact of Hengyuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengyuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengyuan Li more than expected).
Fields of papers citing papers by Hengyuan Li
This network shows the impact of papers produced by Hengyuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengyuan Li. The network helps show where Hengyuan Li may publish in the future.
Co-authorship network of co-authors of Hengyuan Li
This figure shows the co-authorship network connecting the top 25 collaborators of Hengyuan Li. A scholar is included among the top collaborators of Hengyuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengyuan Li. Hengyuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 20 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 8 | |
| 9 | 1 | |
| 10 | 13 | |
| 11 | 22 | |
| 12 | 17 | |
| 13 | 6 | |
| 14 | 1 | |
| 15 | 20 | |
| 16 | 20 | |
| 17 | 2 | |
| 18 | 17 | |
| 19 | 94 | |
| 20 | 14 |
About Hengyuan Li
Hengyuan Li is a scholar working on Pharmaceutical Science, Rheumatology and Oncology, having authored 69 papers that have together received 1.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (17 papers), Bone Tumor Diagnosis and Treatments (12 papers) and Fluorine in Organic Chemistry (9 papers). The work is most often cited by research in Rheumatology (272 citations), Pharmaceutical Science (84 citations) and Cancer Research (180 citations). Hengyuan Li has collaborated with scholars based in China, Australia and Taiwan. Frequent co-authors include Zhaoming Ye, Binghao Li, Lingling Sun, Ting Zhu, Nong Lin, Minghao Zheng, Shengdong Wang, Chuanle Zhu, Tao Xie and Peng Lin. Their work appears in journals such as Small, Science Advances and Clinical Orthopaedics and Related Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.